02773: Histotripsy for Treatment of Canine Appendicular Osteosarcoma

Grant Status: Open

Grant Amount: $35,975
Joanne Tuohy, DVM, PhD; Virginia-Maryland Regional College of Veterinary Medicine
March 1, 2020 - February 28, 2022

Sponsor(s): Bouvier Health Foundation, Golden Retriever Foundation, Newfoundland Club of America Charitable Trust

Breed(s): Irish Setter, Boxer, Scottish Deerhound, Irish Wolfhound, Great Dane, Greyhound, Saint Bernard, -All Dogs, Rottweiler
Research Program Area: Oncology - Osteosarcoma
Donate to Support this Research Program Area

One Health: Yes

Abstract

Osteosarcoma (OS) is the most common bone cancer in dogs. Large and giant breeds such as Irish Wolfhound, Great Dane, Greyhound, Scottish Deerhound, Rottweiler, Boxer, Saint Bernard, and Irish Setter are most affected. OS is treated with a combination of surgical removal of the primary tumor and chemotherapy for metastatic disease. Surgical removal of the tumor usually involves limb amputation or limb salvage surgery, which can have high complication rates, and not all dogs are suitable for limb amputation. Even after surgical tumor removal and chemotherapy, the cancer often metastasizes and dogs usually die of metastatic disease within an average of 12 months after diagnosis. Survival times have not greatly improved over the last 30 years. Histotripsy is a precision non-thermal focused ultrasound method that mechanically breaks down tissues, can potentially induce immune activation towards an anti-OS immune response, and is an emerging modality for treating multiple cancers including liver and brain cancer. A non-surgical option for treatment of the primary tumor in OS will help patients preserve their limb and avoid complications of surgical limb-salvage. A therapy that stimulates an anti-tumor immune response may increase OS survival. This study aims to evaluate the efficacy of histotripsy to treat dogs with OS, to ultimately advance the development of histotripsy as a limb salvage treatment option for primary OS and an immunotherapy treatment against metastatic disease for OS.

Publication(s)

Arnold, L., Hendricks-Wenger, A., Coutermarsh-Ott, S., Gannon, J., Hay, A. N., Dervisis, N., Klahn, S., Allen, I. C., Tuohy, J., & Vlaisavljevich, E. (2021). Histotripsy Ablation of Bone Tumors: Feasibility Study in Excised Canine Osteosarcoma Tumors. Ultrasound in Medicine & Biology. https://doi.org/10.1016/j.ultrasmedbio.2021.08.004

Latifi, M., Hay, A., Carroll, J., Dervisis, N., Arnold, L., Coutermarsh-Ott, S. L., Kierski, K. R., Klahn, S., Allen, I. C., Vlaisavljevich, E., & Tuohy, J. (2021). Focused ultrasound tumour ablation in small animal oncology. Veterinary and Comparative Oncology, 19(3), 411–419. https://doi.org/10.1111/vco.12742

Help Future Generations of Dogs

Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.

Learn How to Help

Connect With Us:
Get Canine Health News:
Please leave this field empty
American Kennel Club Canine Health Foundation, Inc

8051 Arco Corporate Dr.
Suite 300
Raleigh, NC 27617
(888)-682-9696

Tax ID# 13-3813813

   2020 GuideStar logo

© 2020 AKC Canine Health Foundation | Privacy Policy | Site Map

Site by Blackbaud, Inc.

Powered by Blackbaud
nonprofit software